Resolvins and protectins: Novel lipid mediators in anti-inflammation and resolution

Scandinavian Journal of Food and Nutrition

Volumn 50, Issue SUPPL. 2, 2006, Pages 68-78

  Serhan, Charles N ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Anti inflammatory; Aspirin; Human leukocytes; Lipid mediators

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CD59 ANTIGEN; CONNECTIN; CYCLOOXYGENASE 2 INHIBITOR; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INDOMETACIN; LIPID; LIPOXIN; NEUROPROTECTIN; NEUROPROTECTIN D1; OMEGA 3 FATTY ACID; PARACETAMOL; PROTECTIVE AGENT; RESOLVIN D1; RESOLVIN E1; UNCLASSIFIED DRUG;

AGONIST; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR DISEASE; COLITIS; CONFERENCE PAPER; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; EXUDATE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOPHARMACOLOGY; IMMUNOREGULATION; INFLAMMATORY DISEASE; LIPOGENESIS; MASS SPECTROMETRY; MOLECULAR BIOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PERITONITIS; PHENOTYPE; PROTECTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; STROKE; ULTRAVIOLET SPECTROSCOPY;

ANIMALIA; MURINAE;

EID: 33845881699     PISSN: 17482976     EISSN: 17482984     Source Type: Journal    
DOI: 10.1080/17482970601066298     Document Type: Conference Paper

References (51)

1. Burr GO, Burr MM. A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem 1929; 82: 345-67.
2. Lands WEM, ed. Proceedings of the AOCS Short Course on Polyunsaturated Fatty Acids and Eicosanoids. Champaign, IL: American Oil Chemists' Society; 1987.
3. Bazan NG. Supply of n-3 polyunsaturated fatty acids and their significance in the central nervous system. In: Wurtman RJ, Wurtman JJ, eds. Nutrition and the brain. New York: Raven Press; 1990. p. 1-22.
4. Simopoulos AP, Leaf A, Salem N Jr. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J Am Coll Nutr 1999; 18: 487-9.
5. Salem N Jr, Litman B, Kim H-Y, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001; 36: 945-59.
6. Hansson G, Robertson AKL, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol Mech Dis 2006; 1: 297-329.
7. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004; 291: 585-90.
8. Nathan C. Points of control in inflammation. Nature 2002; 420: 846-52.
9. Van Dyke TE, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003; 82: 82-90.
10. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 2005; 115: 2774-83.
11. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000; 192: 1197-204.
12. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J Exp Med 2002; 196: 1025-37.
13. Hong S, Gronert K, Devchand P, Moussignac R-L, Serhan CN. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation. J Biol Chem 2003; 278: 14677-87.
14. Marcheselli VL, Hong S, Lukiw WJ, Hua Tian X, Gronert K, Musto A, et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 2003; 278: 43807-17.
15. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A 2004; 101: 8491-6.
16. Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T, et al. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 2006; 176: 1848-59.
17. Corey EJ, Shih C, Cashman JR. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci U S A 1983; 80: 3581-4.
18. Lee TH, Mencia-Huerta J-M, Shih C, Corey EJ, Lewis RA, Austen KF. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 1984; 74: 1922-33.
19. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, et al. Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005; 201: 713-22.
20. Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 2005; 174: 4345-55.
21. Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, et al. Resolvin E1, a novel endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against TNBS-induced colitis. Proc Natl Acad Sci U S A 2005; 102: 7671-6.
22. Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, et al. RvE1 protects from local inflammation and osteoclast mediated bone destruction in periodontitis. FASEB J 2006; 20: 401-3.
23. Duffield JS, Hong S, Vaidya V, Lu Y, Fredman G, Serhan CN, Bonventre JV. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 2006; 177: 5902-11.
24. Ariel A, Li P-L, Wang W, Tang W-X, Fredman G, Hong S, et al. The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J Biol Chem 2005; 280: 43079-86.
25. Gronert K, Maheshwari N, Khan N, Hassan IR, Dunn M, Schwartzman ML. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem 2005; 280: 15267-78.
26. González-Périz A, Planagumà A, Gronert K, Miquel R, López-Parra M, Titos E, et al. Docosahexanenoic acid (DHA) ameliorates necroinflammatory liver injury by conversion to protective lipid mediators: protectin D1 and 17-hydroxy-DHA. FASEB J 2006;(in press) DOI: 10.1096/fj06-6250fje (http://www.fasebj.org).
27. Samuelsson B. From studies of biochemical mechanisms to novel biological mediators: prostaglandin endoperoxides, thromboxanes and leukotrienes. In: Les Prix Nobel: Nobel Prizes, presentations, biographies and lectures. Stockholm: Almqvist & Wiksell; 1982. p. 153-74.
28. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568-75.
29. Vane JR. Adventures and excursions in bioassay: the stepping stones to prostacyclin. In: Les Prix Nobel: Nobel Prizes, presentations, biographies and lectures. Stockholm: Almqvist & Wiksell; 1982. p. 181-206.
30. Bergström S. The prostaglandins: from the laboratory to the clinic. In: Les Prix Nobel: Nobel Prizes, presentations, biographies and lectures. Stockholm: Almqvist & Wiksell; 1982. p. 129-48.
31. Cotran RS, Kumar V, Collins T, eds. Robbins pathologic basis of disease. 6th edn. Philadelphia, PA: WB Saunders; 1999.
32. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nature Immunol 2005; 6: 1191-7.
33. Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002; 2: 787-95.
34. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nature Immunol 2001; 2: 612-9.
35. Serhan CN, ed. Special Issue on lipoxins and aspirin-triggered lipoxins. Prostaglandins Leukot Essent Fatty Acids 2005;73(3-4).
36. Majno G, Joris I. Cells, tissues and disease: of general pathology. Cambridge, MA: Blackwell Science; 1996.
37. Serhan CN. Lipoxins and aspirin-triggered 15-epilipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat 2002; 68-69: 433-55.
38. Gilroy DW, Lawrence T, Perretti M, Rossi AG. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004; 3: 401-16.
39. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999; 354: 447-55.
40. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105: 1897-903.
41. Bazan NG. Supply, uptake, and utilization of docosahexaenoic acid during photoreceptor cell differentiation. Nestle Nutrition Workshop Series 1992; 28: 121-33.
42. Hamberg M, Samuelsson B. On the specificity of the oxygenation of unsaturated fatty acids catalyzed by soybean lipoxidase. J Biol Chem 1967; 242: 5329-35.
43. Sawazaki S, Salem N Jr, Kim H-Y. Lipoxygenation of docosahexaenoic acid by the rat pineal body. J Neurochem 1994; 62: 2437-47.
44. 4-neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry 2000; 39: 2376-83.
45. VanRollins M, Baker RC, Sprecher HW, Murphy RC. Oxidation of docosahexaenoic acid by rat liver microsomes. J Biol Chem 1984; 259: 5776-83.
46. Winyard PG, Willoughby DA, eds. Inflammation protocols. Totowa, NJ: Humana; 2003.
47. Lu Y, Hong S, Gotlinger K, Serhan CN. Lipid mediator informatics and proteomics in inflammation-resolution. ScientificWorldJournal 2006;6: 589-614.
48. Lu Y, Hong S, Tjonahen E, Serhan CN. Mediator-lipidomics: databases and search algorithms for PUFA-derived mediators. J Lipid Res 2005; 46: 790-802.
49. Rowley AF, Lloyd-Evans P, Barrow SE, Serhan CN. Lipoxin biosynthesis by trout macrophages involves the formation of epoxide intermediates. Biochemistry 1994; 33: 856-63.
50. Bazan NG, Birkle DL, Reddy TS. Docosahexaenoic acid (22:6, n-3) is metabolized to lipoxygenase reaction products in the retina. Biochem Biophys Res Commun 1984; 125: 741-7.
51. Arita M, Bianchini F, Aliberti J, Sher A, Yang R, Petasis NA, et al. Novel omega-3 autacoid resolvin E1: receptor identification and anti-inflammatory properties. J Leukoc Biol 2003;Suppl:31 (Abstract 72).